B. Paul

A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas

T. Olencki, G. Lesinski, J. Schlom, 2016, Cancer Immunology, Immunotherapy.

A Phase I Trial to Evaluate Antibody-Dependent Cellular Cytotoxicity of Cetuximab and Lenalidomide in Advanced Colorectal and Head and Neck Cancer

M. Grever, G. Otterson, P. Trikha, 2016, Molecular Cancer Therapeutics.

The Raf Kinase Inhibitor Sorafenib Inhibits JAK–STAT Signal Transduction in Human Immune Cells

Amanda R. Campbell, M. Caligiuri, J. Byrd, 2008, The Journal of Immunology.

A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma

Amanda R. Campbell, M. Caligiuri, J. Byrd, 2019, Clinical Cancer Research.

Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease

Zachary B. Abrams, G. Lesinski, T. Bekaii-Saab, 2015, Cancer Immunology, Immunotherapy.

A Phase I Trial of Bortezomib and Interferon-a-2b in Metastatic Melanoma

T. Olencki, E. Hade, G. Lesinski, 2014, Journal of immunotherapy.